Queen Mary University of London invites a highly motivated researcher to join the Palacios Lab to identify small molecules that enhance kinesin activity in models of neurodegeneration. The role involves optimizing a cell-based assay and collaborating with AstraZeneca in Cambridge.
The project is MRC-funded for 9 months at 50% FTE, requiring a PhD in cell biology or biochemistry with strong microscopy skills and experience in mammalian tissue culture.
#J-18808-Ljbffr…
